Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | -0.62% | 183.30 | 1.3% | $515.79m | |
| CELG | Celgene Corporation | -0.61% | 92.62 | 1.3% | $442.98m | |
| ARRY | Array BioPharma Inc. | -0.26% | 46.09 | 8.1% | $437.02m | |
| GILD | Gilead Sciences, Inc. | -1.17% | 67.68 | 0.9% | $395.57m | |
| BIIB | Biogen Inc. | -1.44% | 236.83 | 1.3% | $373.10m | |
| ILMN | Illumina, Inc. | -0.68% | 355.63 | 3.5% | $304.33m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -3.10% | 303.21 | 2.6% | $239.55m | |
| VRTX | Vertex Pharmaceuticals Incorporated | -1.01% | 178.33 | 1.9% | $214.81m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -0.68% | 124.30 | 2.0% | $204.89m | |
| EXAS | Exact Sciences Corporation | 0.64% | 112.16 | 24.1% | $190.27m | |
| A | Agilent Technologies, Inc. | -0.33% | 72.27 | 1.6% | $156.70m | |
| BMRN | BioMarin Pharmaceutical Inc. | -0.79% | 83.16 | 4.3% | $126.70m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.70% | 128.75 | 14.7% | $117.49m | |
| INCY | Incyte Corporation | -2.19% | 85.69 | 2.5% | $113.30m | |
| MRTX | Mirati Therapeutics Inc. | -4.31% | 97.74 | 2.5% | $102.89m |
Company Profile
Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. The company was founded by Ronald Cohen in 1995 and is headquartered in Ardsley, NY.